Skip to main content
OpenTrials

Clinical trial condition

Metastatic Urothelial Carcinoma

Explore clinical trials studying Metastatic Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

53 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Urothelial Carcinoma trial results

Completed

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

NCT00942331

Conditions
Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +32 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
View all 873 locations
View Trial Details
Completed

Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma

NCT03513952

Conditions
Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Carcinoma, +40 more
Locations
  • Kaiser Permanente-Riverside Riverside, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Straub Clinic and Hospital Honolulu, Hawaii, United States
  • University of Hawaii Cancer Center Honolulu, Hawaii, United States
View Trial Details
Completed

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

NCT04200963

Conditions
Advanced Cancer, Advanced Solid Tumor, Bladder Cancer, +35 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

SOGUG-AVELUMAB_RWD

NCT05700344

Conditions
Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +3 more
Locations
  • Complexo Hospitalario Universitario de Vigo Vigo, Pontevedra, Spain
  • Complexo Hospitalario Universitario A Coruña A Coruña, Spain
  • Complejo Hospitalario Universitario Albacete Albacete, Spain
  • Complejo Hospitalario Torrecárdenas Almería, Spain
View all 22 locations
View Trial Details

Related conditions